U.S., May 21 -- ClinicalTrials.gov registry received information related to the study (NCT07598396) titled 'A Study to Evaluate Mosunetuzumab in Participants With Systemic Lupus Erythematosus With or Without Active Lupus Nephritis' on Feb. 02.
Brief Summary: This study will assess how mosunetuzumab works in people who have systemic lupus erythematosus (SLE) who may or may not also have active lupus nephritis (LN).
Study Start Date: May 29
Study Type: INTERVENTIONAL
Condition:
Lupus
Systemic Lupus Erythematosus
Lupus Nephritis
Intervention:
DRUG: Mosunetuzumab
Participants will receive SC mosunetuzumab.
Recruitment Status: RECRUITING
Sponsor: Hoffmann-La Roche
Disclaimer: Curated by HT Syndication....